NuVision Pharmacy, Inc.

Form 483 issued July 16, 2014 · Dallas, Texas

Inspection
Jun 3 – Jul 16, 2014
Observations
13
Pages
15
FEI number
3010087152

In short: On July 16, 2014, FDA issued a Form 483 with 13 observations to NuVision Pharmacy, Inc. in Dallas, Texas (FEI 3010087152) after an inspection that ran Jun 3 – Jul 16, 2014. The investigators were Darla J. Christopher and Stephen D. Brown. Most observations concern production and facilities & equipment; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Production and facilities & equipment account for 8 of 13 observations.

Production4
Facilities & equipment4
Laboratory controls3
Quality system2

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly n:view the failure ofa batch or any of its components…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be…

  3. 03

    Aseptic processing areas are deficient regarding the system…

  4. 04

    Aseptic processing areas are deficient regarding systems for maintaining any equipment used to…

9 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at NuVision Pharmacy, Inc.?

FDA listed 13 observations on this Form 483, mostly about production, facilities & equipment and laboratory controls. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected NuVision Pharmacy, Inc.?

Darla J. Christopher and Stephen D. Brown are named on this Form 483, for the inspection of Jun 3 – Jul 16, 2014. Each investigator has a profile showing what they cite most.

When was NuVision Pharmacy, Inc. inspected by FDA?

The inspection ran Jun 3 – Jul 16, 2014, and the Form 483 is dated July 16, 2014.

How do I get the full Form 483 for NuVision Pharmacy, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free